Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J.
| Revenue (Most Recent Fiscal Year) | $6.40B |
| Net Income (Most Recent Fiscal Year) | $864.00M |
| PE Ratio (Current Year Earnings Estimate) | 3.64 |
| PE Ratio (Trailing 12 Months) | 3.39 |
| PEG Ratio (Long Term Growth Estimate) | 1.53 |
| Price to Sales Ratio (Trailing 12 Months) | 0.52 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 7.05 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 2.62 |
| Pre-Tax Margin (Trailing 12 Months) | 12.60% |
| Net Margin (Trailing 12 Months) | 13.49% |
| Return on Equity (Trailing 12 Months) | 340.72% |
| Return on Assets (Trailing 12 Months) | 7.90% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.60 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.11 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 18.77 |
| Inventory Turnover (Trailing 12 Months) | 2.05 |
| Book Value per Share (Most Recent Fiscal Quarter) | $1.83 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.83 |
| Earnings per Share (Most Recent Fiscal Year) | $3.83 |
| Diluted Earnings per Share (Trailing 12 Months) | $3.33 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Common Shares Outstanding | 259.96M |
| Free Float | 256.32M |
| Market Capitalization | $3.36B |
| Average Volume (Last 20 Days) | 4.42M |
| Beta (Past 60 Months) | 0.75 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.40% |
| Percentage Held By Institutions (Latest 13F Reports) | 77.43% |
| Annual Dividend (Based on Last Quarter) | $1.12 |
| Dividend Yield (Based on Last Quarter) | 8.66% |